乳腺手术切口负压伤口治疗的临床与经济影响:荟萃分析
该研究通过系统综述与荟萃分析评估预防性切口负压伤口治疗(iNPWT)在乳腺手术中的有效性与成本效益。成本模型提示仅在高SSI相关费用场景下可能节约成本,支持选择性使用。
要点
- iNPWT与伤口裂开、SSI和皮肤坏死预防率提高相关,但证据确定性低至中等。
- 血清肿、乳头乳晕复合体坏死和血肿无显著差异。
- 成本效益仅在高SSI相关费用场景中可能节约成本,支持选择性使用。
核心结论
- 当前证据未确立预防性iNPWT在乳腺手术中一致的临床获益。
- 成本效益似乎仅限于高风险或高成本场景,支持选择性使用。
研究设计与样本
- 系统综述与随机效应荟萃分析,检索MEDLINE、EMBASE和Cochrane CENTRAL截至2025年3月5日。
- 纳入随机试验及前瞻性或回顾性队列研究,比较预防性iNPWT与标准敷料。
主要发现
- iNPWT与伤口裂开预防率提高相关(RR 1.07,95%CI 1.03至1.12)。
- iNPWT与SSI预防率提高相关(RR 1.05,95%CI 1.01至1.09)。
- iNPWT与皮肤坏死预防率提高相关(RR 1.07,95%CI 1.01至1.15)。
- 血清肿、乳头乳晕复合体坏死和血肿无显著差异。
- 异质性大,95%预测区间跨无效线,证据确定性低至中等。
关键数值与推荐
- 成本模型提示iNPWT仅在高SSI相关费用场景中可能节约成本。
临床怎么用
- 可考虑在高SSI风险或高SSI相关费用场景中选择性使用预防性iNPWT。
- 常规预防性使用证据不足,需结合患者风险与成本评估决策。
局限性
- 异质性大,95%预测区间跨无效线,未来场景效应方向不确定。
- 证据确定性范围为低至中等。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Wound complications after breast surgery are common and contribute to morbidity and healthcare costs. The economic value of prophylactic incisional negative-pressure wound therapy (iNPWT) remains uncertain. This study evaluated the effectiveness and cost-effectiveness of iNPWT in preventing postoperative wound complications (freedom from complication) following breast surgery through a systematic review and meta-analysis. METHODS: MEDLINE, EMBASE, and the Cochrane Central Register of Controlled Trials were searched without any restrictions up to 5 March 2025. Randomized trials and prospective or retrospective cohort studies comparing prophylactic iNPWT with standard dressings were included. Two reviewers independently extracted data, assessed risk of bias (RoB 2, ROBINS-I), and graded evidence certainty (GRADE). Random-effects meta-analyses were performed, and cost-effectiveness modelling focused on surgical site infection (SSI). RESULTS: Twenty-nine studies including 4904 patients (1817 iNPWT; 3087 controls) were analysed. iNPWT was associated with higher rates of wound dehiscence prevention (RR 1.07, 95% c.i. 1.03 to 1.12), SSI prevention (RR 1.05, 95% c.i. 1.01 to 1.09), and skin necrosis prevention (RR 1.07, 95% c.i. 1.01 to 1.15). No significant differences were observed for seroma, nipple-areolar complex necrosis, or haematoma. Across outcomes, heterogeneity was substantial and 95% prediction intervals crossed the null, indicating uncertainty in the direction of effect in future settings. Evidence certainty ranged from low to moderate. Cost modelling suggested that iNPWT may be cost-saving only in settings with high SSI-related costs. CONCLUSIONS: Current evidence does not establish consistent clinical benefit of prophylactic iNPWT in breast surgery. Cost-effectiveness appears limited to high-risk or high-cost contexts, supporting selective use.
引用
- Kollatos C, Sackey H, Pantiora E, et al. Clinical and economic impact of incisional negative pressure wound therapy in breast surgery: meta-analysis. Br J Surg. 2026. PMID: 42084358. doi:10.1093/bjs/znag056
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。